These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 23621618)

  • 1. Pharmacokinetic evaluation of bazedoxifene for the treatment of osteoporosis.
    Gatti D; Rossini M; Sblendorio I; Lello S
    Expert Opin Drug Metab Toxicol; 2013 Jul; 9(7):883-92. PubMed ID: 23621618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of bazedoxifene, a novel selective estrogen receptor modulator for the prevention and treatment of postmenopausal osteoporosis.
    Palacios S
    Curr Med Res Opin; 2010 Jul; 26(7):1553-63. PubMed ID: 20429824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conjugated estrogens combined with bazedoxifene: the first approved tissue selective estrogen complex therapy.
    Sharifi M; Lewiecki EM
    Expert Rev Clin Pharmacol; 2014 May; 7(3):281-91. PubMed ID: 24580081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bazedoxifene and bazedoxifene combined with conjugated estrogens for the management of postmenopausal osteoporosis.
    Lewiecki EM
    Expert Opin Investig Drugs; 2007 Oct; 16(10):1663-72. PubMed ID: 17922629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue-selective estrogen complexes for postmenopausal women.
    Mirkin S; Komm BS
    Maturitas; 2013 Nov; 76(3):213-20. PubMed ID: 23849704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bazedoxifene: a new selective estrogen receptor modulator for postmenopausal osteoporosis.
    Genant HK
    Menopause Int; 2011 Jun; 17(2):44-9. PubMed ID: 21693498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bazedoxifene/conjugated estrogens for menopausal symptom treatment and osteoporosis prevention.
    Pinkerton JV; Pickar JH; Racketa J; Mirkin S
    Climacteric; 2012 Oct; 15(5):411-8. PubMed ID: 22853444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The evolving role of oral hormonal therapies and review of conjugated estrogens/bazedoxifene for the management of menopausal symptoms.
    Parish SJ; Gillespie JA
    Postgrad Med; 2017 Apr; 129(3):340-351. PubMed ID: 28132583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bazedoxifene: a new selective estrogen receptor modulator for the treatment of postmenopausal osteoporosis.
    Kung AW; Chu EY; Xu L
    Expert Opin Pharmacother; 2009 Jun; 10(8):1377-85. PubMed ID: 19445558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bazedoxifene: a selective estrogen-receptor modulator.
    Mitwally MF
    Womens Health (Lond); 2008 Jul; 4(4):319-26. PubMed ID: 19072496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bazedoxifene + conjugated estrogens in HT for the prevention of osteoporosis and treatment of vasomotor symptoms associated with the menopause.
    Tella SH; Gallagher JC
    Expert Opin Pharmacother; 2013 Dec; 14(17):2407-20. PubMed ID: 24093499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bazedoxifene/conjugated estrogens combination for the treatment of the vasomotor symptoms associated with menopause and for prevention of osteoporosis in postmenopausal women.
    Palacios S; Mejía Ríos A
    Drugs Today (Barc); 2015 Feb; 51(2):107-16. PubMed ID: 25756066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bazedoxifene when paired with conjugated estrogens is a new paradigm for treatment of postmenopausal women.
    Pinkerton JV; Stovall DW
    Expert Opin Investig Drugs; 2010 Dec; 19(12):1613-21. PubMed ID: 21073353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bazedoxifene: a novel selective estrogen receptor modulator for postmenopausal osteoporosis.
    de Villiers TJ
    Climacteric; 2010 Jun; 13(3):210-8. PubMed ID: 20184423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bazedoxifene (Wyeth).
    Gruber C; Gruber D
    Curr Opin Investig Drugs; 2004 Oct; 5(10):1086-93. PubMed ID: 15535430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conjugated estrogens/bazedoxifene (Duavee) for menopausal symptoms and prevention of osteoporosis.
    Med Lett Drugs Ther; 2014 Apr; 56(1441):33-4. PubMed ID: 24759293
    [No Abstract]   [Full Text] [Related]  

  • 17. Bazedoxifene: bazedoxifene acetate, TSE 424, TSE-424, WAY 140424.
    Drugs R D; 2008; 9(3):191-6. PubMed ID: 18457472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bazedoxifene as a new-generation SERM].
    Ohta H
    Clin Calcium; 2011 Jan; 21(1):34-42. PubMed ID: 21187592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gynecologic Safety of Conjugated Estrogens Plus Bazedoxifene: Pooled Analysis of Five Phase 3 Trials.
    Mirkin S; Pinkerton JV; Kagan R; Thompson JR; Pan K; Pickar JH; Komm BS; Archer DF
    J Womens Health (Larchmt); 2016 May; 25(5):431-42. PubMed ID: 27058301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective estrogen receptor modulators and the combination therapy conjugated estrogens/bazedoxifene: A review of effects on the breast.
    Pickar JH; Komm BS
    Post Reprod Health; 2015 Sep; 21(3):112-21. PubMed ID: 26289836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.